MedBright AI Appointments Brandon Kou as Director
MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF) has appointed Brandon Kou as Director, effective February 3, 2025, replacing Jaime Gerber. Kou brings significant experience as Managing Director at Wildcat Equity Partners and former CEO of Leef Brands, where he led multiple acquisitions and a major merger in California. His background includes co-founding Block Partners and Mavan Capital Partners, as well as managing Steve Nash Enterprises' portfolio of companies.
Kou's expertise spans M&A, public markets, and investment banking, with previous experience at Houlihan Lokey and a degree from USC's Marshall School of Business. The company has granted 1,250,000 options to directors and officers at $0.035 with a five-year term.
MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF) ha nominato Brandon Kou come Direttore, con effetto dal 3 febbraio 2025, sostituendo Jaime Gerber. Kou porta una significativa esperienza come Managing Director presso Wildcat Equity Partners e ex CEO di Leef Brands, dove ha guidato diverse acquisizioni e una grande fusione in California. Il suo background include la co-fondazione di Block Partners e Mavan Capital Partners, oltre alla gestione del portafoglio di aziende di Steve Nash Enterprises.
La competenza di Kou abbraccia M&A, mercati pubblici e investment banking, con esperienza precedente presso Houlihan Lokey e una laurea presso la Marshall School of Business dell'USC. L'azienda ha concesso 1.250.000 opzioni a direttori e funzionari a $0,035 con un termine di cinque anni.
MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF) ha nombrado a Brandon Kou como Director, a partir del 3 de febrero de 2025, reemplazando a Jaime Gerber. Kou aporta una experiencia significativa como Managing Director en Wildcat Equity Partners y ex-CEO de Leef Brands, donde lideró múltiples adquisiciones y una importante fusión en California. Su trayectoria incluye ser cofundador de Block Partners y Mavan Capital Partners, así como la gestión del portafolio de empresas de Steve Nash Enterprises.
La expertise de Kou abarca M&A, mercados públicos y banca de inversión, con experiencia previa en Houlihan Lokey y un título de la Marshall School of Business de la USC. La compañía ha otorgado 1.250.000 opciones a directores y funcionarios a $0.035 con un plazo de cinco años.
MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF)는 Brandon Kou를 이사로 임명했습니다. 임기는 2025년 2월 3일부터 발효되며, Jaime Gerber를 대체합니다. Kou는 Wildcat Equity Partners의 상무이사와 Leef Brands의 전 CEO로서 여러 인수와 캘리포니아에서의 주요 합병을 이끈 중요한 경험을 가지고 있습니다. 그의 경력에는 Block Partners와 Mavan Capital Partners의 공동 설립이 포함되어 있으며, Steve Nash Enterprises의 기업 포트폴리오 관리도 수행했습니다.
Kou의 전문 분야는 M&A, 공공 시장, 투자은행을 포함하며, 이전에는 Houlihan Lokey에서 일했으며 USC의 Marshall School of Business에서 학위를 받았습니다. 회사는 이사 및 임원에게 1,250,000개의 옵션을 $0.035에 부여하고 5년 동안 유효합니다.
MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF) a nommé Brandon Kou au poste de Directeur, à compter du 3 février 2025, remplaçant Jaime Gerber. Kou apporte une expérience significative en tant que Managing Director chez Wildcat Equity Partners et ancien CEO de Leef Brands, où il a dirigé plusieurs acquisitions et une grande fusion en Californie. Son parcours comprend la co-fondation de Block Partners et Mavan Capital Partners, ainsi que la gestion du portefeuille d'entreprises de Steve Nash Enterprises.
L'expertise de Kou couvre les fusions et acquisitions, les marchés publics et la banque d'investissement, avec une expérience antérieure chez Houlihan Lokey et un diplôme de la Marshall School of Business de l'USC. La société a accordé 1 250 000 options à des directeurs et des fonctionnaires au prix de 0,035 $ avec une durée de cinq ans.
MedBright AI Investments (CSE:MBAI, OTCQB:MBAIF) hat Brandon Kou zum Direktor ernannt, ab dem 3. Februar 2025, und ersetzt damit Jaime Gerber. Kou bringt bedeutende Erfahrungen als Managing Director bei Wildcat Equity Partners und ehemaliger CEO von Leef Brands mit, wo er mehrere Übernahmen und eine große Fusion in Kalifornien leitete. Sein Hintergrund umfasst die Mitbegründung von Block Partners und Mavan Capital Partners sowie das Management des Portfolios von Steve Nash Enterprises.
Kous Expertise erstreckt sich über M&A, öffentliche Märkte und Investment Banking, wobei er zuvor bei Houlihan Lokey tätig war und einen Abschluss an der Marshall School of Business der USC hat. Das Unternehmen hat 1.250.000 Optionen an Direktoren und Beamte zu je $0,035 mit einer Laufzeit von fünf Jahren gewährt.
- Appointment of experienced director with strong M&A and capital markets background
- New director brings relevant experience in healthcare, technology, and public markets
- Previous success in leading company acquisitions and mergers as CEO
- None.
VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) is pleased to announce that Brandon Kou has joined MedBright AI as a Director, effective February 3, 2025, replacing Jaime Gerber.
Brandon Kou is a Managing Director at Wildcat Equity Partners, a family office based in the US investing in healthcare, media, technology, and infrastructure.
Previously, he was CEO and board member of Leef Brands, a publicly traded MSO (multi-state operator) in the legalized cannabis space. Under his guidance, Leef acquired multiple brands and companies leading to an eventual merger with one of the largest manufactures in the state of California. Mr. Kou was responsible for all aspects of the business including M&A, all public market activities and general strategy for the company taking it from a small single brand focused company to one of the largest operators in the US.
Mr. Kou co-founded Block Partners, a merchant banking and advisory group for blockchain and distributed ledger technology companies. He also co-founded Mavan Capital Partners, an investment firm focused on bringing technology opportunities to the Canadian capital markets.
Earlier, Mr. Kou was Co-Founder and General Manager of Steve Nash Enterprises, managing a portfolio of companies in media/entertainment, sports, and health/wellness, including Indochino, Sharecare, the Vancouver Whitecaps, Onebode and the Steve Nash Sports Club and Fitness World. He also ran Meathawk, a film production company. In addition to his responsibilities at Steve Nash Enterprises, Mr. Kou served as a Board of Directors proxy for Steve Nash Sports Club and Fitness World, a growing chain fitness clubs in Vancouver co-founded by Mark Mastrov.
Mr. Kou's background includes investment banking at Houlihan Lokey, and he brings strong knowledge and experience within the capital markets. He holds a degree from USC's Marshall School of Business.
The Company announces that 1,250,000 options have been granted to certain directors and officers at
The Company expresses appreciation to Dr. Jamie Gerber for his contribution and wishes him the best in his future endeavours.
About MedBright AI Investments Inc.
Medbright AI is a capital allocator focused on investing in diversified industries, including technology, health care and artificial intelligence. These include both public and private companies. Medbright has a focus on near-term and midterm high-quality opportunities with strong return potentials while maintaining its commitment to governance.
For further information, please contact:
MedBright AI Investments Inc.
Mr. Christopher Cherry, Interim Chief Executive Officer
Email: investors@medbright.ai
Phone: (604) 602-0001
www.medbright.ai
FAQ
Who is the new director appointed to MedBright AI (MBAIF) in February 2025?
What stock options did MedBright AI (MBAIF) grant in February 2025?
What is Brandon Kou's current role besides being director at MedBright AI (MBAIF)?
What was Brandon Kou's major achievement as CEO of Leef Brands before joining MBAIF?
